🇺🇸 Recombinant Zoster Vaccine in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Pain — 1 report (10%)
  2. Arthralgia — 1 report (10%)
  3. Cystitis — 1 report (10%)
  4. Diarrhoea Haemorrhagic — 1 report (10%)
  5. Disease Recurrence — 1 report (10%)
  6. Faecal Calprotectin Increased — 1 report (10%)
  7. Herpes Zoster Disseminated — 1 report (10%)
  8. Nausea — 1 report (10%)
  9. Therapeutic Product Effect Decreased — 1 report (10%)
  10. Urosepsis — 1 report (10%)

Source database →

Recombinant Zoster Vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Recombinant Zoster Vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Recombinant Zoster Vaccine in United States?

Wuhan BravoVax Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.